[Prevention after acute coronary syndrome].
Mortality is increased in acute coronary syndrome (ACS) related to the extent of myocardial injury even if percutaneous coronary intervention (PCI) was successful. The development of congestive heart failure (CHF) after PCI in ACS is of prognostic interest. Non-invasive imaging plays a major role for determination of structural myocardial damage and loss of function. Secondary prevention regarding pharmacologic and non-pharmacologic therapy is dependent on myocardial function and the presence or absence of CHF. Exercise training as part of the non-pharmacological therapy plays an important role in rehabilitation after ACS according to the severity of injury.
Klinik für Kardiologie und Angiologie, Evangelisches Krankenhaus Oberhausen.
G
G
Horstick
D054058:Acute Coronary Syndrome / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D000789:Angina, Unstable / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D015906:Angioplasty, Balloon, Coronary; D002423:Cause of Death; D017023:Coronary Angiography; D015716:Electrocardiography, Ambulatory; D005081:Exercise Therapy; D006333:Heart Failure / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D040242:Risk Reduction Behavior; D055502:Secondary Prevention; D012815:Signal Processing, Computer-Assisted; D015607:Stents; D015996:Survival Rate
D010975:Platelet Aggregation Inhibitors